The effects of methylphenidate on weight, height, and body mass index in Turkish children and adolescents with ADHD

被引:3
|
作者
Turan, Serkan [1 ]
PEKCANLAR Akay, Aynur [2 ]
机构
[1] Odemis State Hosp, Dept Child & Adolescent Psychiat, TR-35750 Izmir, Turkey
[2] Dokuz Eylul Univ, Dept Child & Adolescent Psychiat, Med Fac, Izmir, Turkey
来源
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY | 2020年 / 21卷 / 02期
关键词
methylphenidate; attention-deficit hyperactivity disorder; height; weight; BMI; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; GROWTH; ASSOCIATION;
D O I
10.5455/apd.51135
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The pathophysiological mechanisms underlying the effects of psychostimulants (methylphenidate) treatment on growth still remain controversial. We examined the long term effects of methylphenidate on height, weight and body mass index in Turkish children and adolescents with attention deficit hyperactivity disorder (ADHD). Methods: Participants (6-18 years, 330 boys, 103 girls) diagnosed with ADHD who received treatment with methylphenidate for at least 1 year at the Department of Child and Adolescent Psychiatry at Dokuz Eylul University Medical School were included in a retrospective study. Weight, height, and BMI z scores were converted to age- and gender-corrected z scores using norms from the Turkish population at baseline and last follow-up. Results: Height and weight standard deviation score (SDS) were reduced by treatment (baseline height-SDS (SDS]: 0.74 +/- 1.43, followup height-SDS [SDS]: -0.67 +/- 4.35, t-test p<0.001; baseline weight SDS [SDS]: 0.61 +/- 1.28, and follow-up weight-SDS [SDS]: -0.41 +/- 0.76, t-test p<0.001). There were no differences in BMI-SDS before and after stimulant treatment (baseline BMI-SDS [SDS]: 0.27 +/- 1.21, follow-up BMI-SDS [SDS]: -0.20 +/- 4.54, t-test p=0.353). However, considering whether patients were children (6-12 years) or adolescents (13-18 years) when they started medication, in the group of children, height and BMI was affected by treatment (baseline height-SDS [SDS]: 0.87 +/- 1.42; follow-up height-SDS [SDS]: -0.78 +/- 4.81]; p=0.002; baseline BMI-SDS [SDS]: 0.29 +/- 1.19; follow-up BMI-SDS [SDS]: -0.21 +/- 0.69; p<0.001). Results of multiple linear regression analysis which assess the possible contribution of the different treatment-related factors, only age starting treatment (B=-0.039, p=0.011) predicted final weight. Conclusions: We conclude that methylphenidate shows a negative effect on height and BMI in children. It was thought that the findings obtained at the end of the study might be helpful in assessing the growth parameters that may facilitate the course of the ADHD, and in the improvement of more efficient and permanent treatment approaches, and the adherence of patients to the treatment.
引用
收藏
页码:211 / 217
页数:7
相关论文
共 50 条
  • [31] Height, weight and body mass index of children with congenital cataracts before surgical treatment
    Jingjing Chen
    Duoru Lin
    Zhuoling Lin
    Xiaoyan Li
    Qianzhong Cao
    Zhenzhen Liu
    Erping Long
    Xiaohang Wu
    Li Zhang
    Xiaojia Zhou
    Lisha Wang
    Jing Li
    Jun Fu
    Haotian Lin
    Weirong Chen
    Yizhi Liu
    BMC Ophthalmology, 17
  • [32] Moderators and Other Predictors of Methylphenidate Response in Children and Adolescents with ADHD
    D'Aiello, Barbara
    Di Vara, Silvia
    De Rossi, Pietro
    Pretelli, Italo
    Vicari, Stefano
    Menghini, Deny
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (03)
  • [33] Predicting the Response of Children and Adolescents With ADHD to Methylphenidate: A Systematic Review
    Pagnier, Maryse
    JOURNAL OF ATTENTION DISORDERS, 2023, 27 (12) : 1377 - 1392
  • [34] Reduced pain perception in children and adolescents with ADHD is normalized by methylphenidate
    Wolff, Nicole
    Rubia, Katya
    Knopf, Hildtraud
    Hoelling, Heike
    Martini, Julia
    Ehrlich, Stefan
    Roessner, Veit
    CHILD AND ADOLESCENT PSYCHIATRY AND MENTAL HEALTH, 2016, 10
  • [35] Growth in achondroplasia: Development of height, weight, head circumference, and body mass index in a European cohort
    Merker, Andrea
    Neumeyer, Luitgard
    Hertel, Niels Thomas
    Grigelioniene, Giedre
    Makitie, Outi
    Mohnike, Klaus
    Hagenas, Lars
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2018, 176 (08) : 1723 - 1734
  • [36] Cross-sectional Growth Curves for Height, Weight and Body Mass Index for Affluent Indian Children, 2007
    Khadilkar, V. V.
    Khadilkar, A. V.
    Cole, T. J.
    Sayyad, M. G.
    INDIAN PEDIATRICS, 2009, 46 (06) : 477 - 489
  • [37] Methylphenidate Use for Emotional Dysregulation in Children and Adolescents with ADHD and ADHD and ASD: A Naturalistic Study
    Ventura, Patrizia
    de Giambattista, Concetta
    Trerotoli, Paolo
    Cavone, Maddalena
    Di Gioia, Alessandra
    Margari, Lucia
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (10)
  • [38] Investigation of maximum mouth opening in terms of age, weight, height and body mass index in Turkish adult population
    Demir, Mehmet Gokhan
    CRANIO-THE JOURNAL OF CRANIOMANDIBULAR & SLEEP PRACTICE, 2023,
  • [39] New Finnish growth references for children and adolescents aged 0 to 20 years: Length/height-for-age, weight-for-length/height, and body mass index-for-age
    Saari, Antti
    Sankilampi, Ulla
    Hannila, Marja-Leena
    Kiviniemi, Vesa
    Kesseli, Kari
    Dunkel, Leo
    ANNALS OF MEDICINE, 2011, 43 (03) : 235 - 248
  • [40] Attributions and Perception of Methylphenidate Effects in Adolescents With ADHD
    Pelham, William E., Jr.
    Gnagy, Elizabeth M.
    Sibley, Margaret H.
    Kipp, Heidi L.
    Smith, Bradley H.
    Evans, Steven W.
    Bukstein, Oscar
    JOURNAL OF ATTENTION DISORDERS, 2017, 21 (02) : 129 - 136